Benzinga - Gainers
- Nogin, Inc. (NASDAQ: NOGN) shares surged 172.4% to $7.41.
- Guardforce AI Co., Limited (NASDAQ: GFAI) jumped 101% to $14.24 after climbing 50% on Friday.
- Harbor Custom Development, Inc. (NASDAQ: HCDI) surged 48% to $6.42. On Friday, Harbor Custom Development reported worse-than-expected Q4 sales results.
- U.S. Energy Corp. (NYSE: USEG) gained 31.3% to $2.31.
- Cano Health, Inc. (NYSE: CANO) rose 30% to $1.1850. Barry Sternlicht, on April 2, entered into group agreement with Elliot Cooperstone, Lewis Gold, Agreed to act together to pursue change at Cano Health.
- Mangoceuticals, Inc. (NASDAQ: MGRX) gained 26% to $1.4421.
- Brera Holdings PLC (NASDAQ: BREA) jumped 26% to $3.9711.
- Barnwell Industries, Inc. (NYSE: BRN) gained 25.5% to $2.76.
- VNET Group, Inc. (NASDAQ: VNET) shares climbed 23.2% to $3.99 after gaining 8% on Friday.
- Indonesia Energy Corporation Limited (NASDAQ: INDO) surged 22.2% to $5.83 after gaining 3% on Friday.
- Heska Corporation (NASDAQ: HSKA) jumped 20% to $117.36 after Mars announced it would acquire the company for $120/share.
- New Concept Energy, Inc. (NYSE: GBR) surged 18.8% to $1.26. New Concept Energy recently posted a profit for the fourth quarter.
- InterCure Ltd. (NASDAQ: INCR) gained 18.1% to $2.41 after the company reported record fiscal year 2022 revenue of $150 million.
- Hammerhead Energy Inc. (NASDAQ: HHRS) rose 18.1% to $8.86.
- Allarity Therapeutics, Inc. (NASDAQ: ALLR) surged 16.7% to $1.96. Allarity Therapeutics recently filed for offering of up to 3.9 million common shares.
- VirTra, Inc. (NASDAQ: VTSI) gained 16.4% to $4.69 after reporting a profit for the fourth quarter.
- BP Prudhoe Bay Royalty Trust (NYSE: BPT) climbed 16.4% to $8.90.
- Spark Networks SE (NYSE: LOV) gained 15.9% to $0.7774. Spark Networks recently reported worse-than-expected Q4 sales results.
- Alpine Summit Energy Partners, Inc. (NASDAQ: ALPS) surged 15.7% to $0.6136.
- Teck Resources Limited (NYSE: TECK) jumped 14.5% to $41.79 after the company's board of directors rejected the unsolicited acquisition offer from Glencore.
- Tango Therapeutics, Inc. (NASDAQ: TNGX) surged 12.6% to $4.4484. Tango Therapeutics reported FDA clearance of investigational new drug application for TNG260, a first-in-class CoREST inhibitor for treatment of STK11-mutant cancers.
- Hitek Global Inc. (NASDAQ: HKIT) gained 12.2% to $6.24 after gaining 11% on Friday. Hitek Global priced its initial public offering of 3,200,000 ordinary shares at a price of $5.00 per ordinary share.
- ProPetro Holding Corp. (NYSE: PUMP) jumped 8.8% to $7.82
- Kingsoft Cloud Holdings Limited (NASDAQ: KC) gained 8.1% to $9.61after gaining 13% on Friday. Kingsoft Cloud Holdings recently reported a fourth-quarter FY22 revenue decline of 19.9% year-on-year to $308.9 million, beating the consensus of $302.9 million.
- IVERIC bio, Inc. (NASDAQ: ISEE) climbed 8% to $26.27.
- Marathon Oil Corporation (NYSE: MRO) gained 7.8% to $25.84 amid a rise in oil prices after OPEC+ producers announced a production cut.
- ConocoPhillips (NYSE: COP) rose 7.7% to $106.86 amid a rise in oil prices after OPEC+ producers announced a production cut.
3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or
remove ads
.
Losers- OncoSec Medical Incorporated (NASDAQ: ONCS) shares dipped 52.7% to $1.22 after the company announced the primary endpoint of the overall response rate from the Phase 2 KEYNOTE-695 clinical trial was not met.
- Palisade Bio, Inc. (NASDAQ: PALI) fell 36.1% to $2.25 after the company announced a $6 million registered direct offering and concurrent private placement priced above the market under Nasdaq rules.
- United Homes Group, Inc. (NASDAQ: UHG) fell 31.3% to $14.26 after jumping around 64% on Friday.
- Ascendis Pharma A/S (NASDAQ: ASND) fell 27.9% to $77.26 after the FDA identified deficiencies in the company's New Drug Application for Transcon PTH.
- Biodexa Pharmaceuticals Plc (NASDAQ: BDRX) dropped 24.8% to $0.2929.
- Micromobility.com Inc. (NASDAQ: MCOM) dropped 24.8% to $2.75. micromobillity.com announced the introduction of same-day delivery options for customers in New York City starting in May 2023.
- Eastside Distilling, Inc. (NASDAQ: EAST) fell 23.1% to $0.2691 after reporting weaker-than-expected Q4 results.
- Minim, Inc. (NASDAQ: MINM) dipped 22.1% to $0.0848 after the company announced a 1-for-25 reverse stock split.
- ENGlobal Corporation (NASDAQ: ENG) dipped 20.7% to $0.38.
- Annovis Bio, Inc. (NYSE: ANVS) dropped 19.3% to $12.43. Annovis Bio received interim analysis for sample size re-estimation for its Phase 3 clinical trial for treatment of early Parkinson's disease.
- Apollomics, Inc. (NASDAQ: APLM) fell 17.7% to $24.20 after the company began trading on the Nasdaq last week.
- Nexters Inc. (NASDAQ: GDEV) fell 17.5% to $5.66.
- Semler Scientific, Inc. (NASDAQ: SMLR) dipped 17.3% to $22.16. Semler Scientific recently reported better-than-expected Q4 EPS and sales results.
- G Medical Innovations Holdings Ltd (NASDAQ: GMVD) dropped 15.7% to $0.7665. G Medical recently announced pricing of a public offering.
- Inpixon (NASDAQ: INPX) shares fell 13.4% to $0.3720. Inpixon shares gained 16% on Friday after the company reported 2022 financial results and provided a business update.
- Amprius Technologies, Inc. (NYSE: AMPX) dropped 11.6% to $7.70.
- Crown ElectroKinetics Corp. (NASDAQ: CRKN) fell 11.3% to $0.1270 after dropping 15% on Friday. Crown Electrokinetics posted a FY22 loss of $0.82 per share.
- BGC Partners, Inc. (NASDAQ: BGCP) dropped 10.8% to $4.6620.
- SIGNA Sports United N.V. (NYSE: SSU) fell 10.6% to $4.06.
- Kodiak Sciences Inc. (NASDAQ: KOD) declined 10.5% to $5.55. Kodiak Sciences announced that the first patient has been treated in the Phase 1 study of Ksi-501, targeting both VEGF and IL-6, the second product candidate built on Kodiak's antibody biopolymer conjugate platform to enter the clinic.
- DHT Holdings, Inc. (NYSE: DHT) fell 10.5% to $9.66.
- Frontline plc (NYSE: FRO) fell 9.2% to $14.99.
- TORM plc (NASDAQ: TRMD) fell 8.6% to $28.44. TORM shares gained 9% on Friday after the company announced termination of a secondary public offering of its Class A common shares by a selling shareholder.
3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or
remove ads
.
© 2023 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.